Form 4: Alector Chief Medical Officer Sells Shares to Cover Tax Obligations

Alector's Chief Medical Officer, Gary Romano, sold 14,892 shares of common stock to cover tax obligations related to vesting restricted stock units.

Summary

• Gary Romano, the Chief Medical Officer of Alector, Inc., sold 14,892 shares of common stock on December 2, 2024.
• The sale was executed to satisfy tax obligations arising from the vesting of restricted stock units (RSUs).
• The shares were sold at a weighted average price of $2.5194, with individual transactions ranging from $2.5194 to $2.5197.
• Following the transaction, Mr. Romano directly owns 349,283 shares of Alector common stock.

Sentiment

Score: 5

Explanation: This is a neutral event, a routine transaction for an executive to cover tax obligations. It doesn't indicate a positive or negative outlook for the company.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Sales of shares by executives to cover tax obligations are a common practice across the biotechnology industry.
• Similar transactions are regularly reported by executives at companies like Biogen, Amgen, and Regeneron, when their stock options or restricted stock units vest.

Stakeholder Impact

• The sale has a minimal impact on shareholders as it is a routine transaction for an executive.

Key Dates

Keywords

Alector, insider trading, stock sale, Form 4, Chief Medical Officer, Gary Romano, restricted stock units, tax obligations